Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BY-NCCurrent therapeutic research, clinical and experimental

Population pharmacokinetic modeling of adalimumab biosimilar SCT630 and Humira® in healthy participants and patients with moderate to severe plaque psoriasis to establish PK similarity

  • Dongyang Li1
  • Yuhuan Jiao1
  • Kun Wu1
  • Hongyun Ma1
  • Qianqian Hong1
  • Liangzhi Xie1
  1. 1Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, 100176, China
Read full textPDFCite

Related

  1. Steady-State Pharmacokinetic Drug-Drug Interaction Study of Zastaprazan, a Novel Potassium-Competitive Acid Blocker, and Atorvastatin in Healthy Participants.
    A-Young Yang, Hongsock Kim, Hyounggyoon Yoo +3
    Drug design, development and therapyPeer-reviewedCC BY-NCFull textPharmacology & toxicologyEurope PMC
  2. Criterion‐Related Validity of the Couple Flourishing Measure in a Spanish Population: Distinguishing Outpatients From Community Participants
    Alejandro Saavedra‐Roa, Martiño Rodríguez‐González, Claudia Pineda‐Marín +2
    Family processPeer-reviewedCC BY-NC-NDFull textPsychiatry & mental healthEurope PMC
  3. Electronic-Nomogram-Guided Micafungin Dosing Regimen in Critically Ill Patients: A Population Pharmacokinetic Study
    Jean-Joseph Bendjilali-Sabiani, Ahlem Gammoudi, Matthieu Conseil +2
    International Journal of Antimicrobial AgentsPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseaseHAL
  4. Handling missed dose of riluzole by population pharmacokinetic model informed remedial regimen
    Changlong Liu, Qing Tang, Lingyan Yu +1
    Frontiers in pharmacologyPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCCrossref
  5. Comparison of Trough-Only and Peak–Trough Concentration Data for the Calculation of Vancomycin Area under the Concentration–Time Curve on Day 2 Using Previous and Updated Population Pharmacokinetic Models
    Takashi Niwa, Yuto Yamada, Kazuyuki Sumi +10
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull text1 citedPharmacology & toxicologyJ-STAGE

Cite

BibTeXRIS
BibTeX
@article{li2026population,
  title = {{Population pharmacokinetic modeling of adalimumab biosimilar SCT630 and Humira® in healthy participants and patients with moderate to severe plaque psoriasis to establish PK similarity}},
  author = {Dongyang Li and Yuhuan Jiao and Kun Wu and Hongyun Ma and Qianqian Hong and Liangzhi Xie},
  journal = {Current therapeutic research, clinical and experimental},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13675741},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Population pharmacokinetic modeling of adalimumab biosimilar SCT630 and Humira® in healthy participants and patients with moderate to severe plaque psoriasis to establish PK similarity
AU  - Dongyang Li
AU  - Yuhuan Jiao
AU  - Kun Wu
AU  - Hongyun Ma
AU  - Qianqian Hong
AU  - Liangzhi Xie
PY  - 2026
DA  - 2026/09/30
JO  - Current therapeutic research, clinical and experimental
UR  - https://europepmc.org/article/PMC/PMC13675741
SN  - 0011-393X
SN  - 1879-0313
ER  -